{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:34:25Z","timestamp":1782603265207,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.msard.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T11:41:15Z","timestamp":1441280475000},"page":"495-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Natalizumab-induced hepatic injury: A case report and review of literature"],"prefix":"10.1016","volume":"4","author":[{"given":"A","family":"Antezana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Kister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2015.08.008_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.dld.2011.11.003","article-title":"Severe acute autoimmune hepatitis after natalizumab treatment","volume":"44","author":"Lisotti","year":"2012","journal-title":"Dig. Liver Dis."},{"issue":"9","key":"10.1016\/j.msard.2015.08.008_bib2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1365-2036.2010.04262.x","article-title":"Clinically significant liver injury in patients treated with natalizumab","volume":"31","author":"Bezabeh","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.msard.2015.08.008_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1177\/1352458512463485","article-title":"Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis","volume":"19","author":"Martinez-Lapiscina","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2015.08.008_bib4","first-page":"S271","article-title":"Acute Liver Dysfunction after Addition of Natalizumab to Interferon in Two Patients with MS","volume":"102","author":"Michael","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.msard.2015.08.008_bib5","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1212\/NXI.0000000000000072","article-title":"Fatal liver failure with hepatitis B virus infection during natalizumab treatment in multiple sclerosis","volume":"2","author":"Hillen","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2015.08.008_bib111","unstructured":"Kader ME et al., Autoimmune hepatitis: 2 case reports. Reactions weekly 2007. link.springer.com\/...\/00128415-200711750-00062"},{"issue":"12","key":"10.1016\/j.msard.2015.08.008_bib6","doi-asserted-by":"crossref","first-page":"e81685","DOI":"10.1371\/journal.pone.0081685","article-title":"Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients","volume":"8","author":"Mellerg\u00e5rd","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.msard.2015.08.008_bib7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1212\/WNL.0b013e3182a84101","article-title":"Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis","volume":"81","author":"Warnke","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2015.08.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2613.2003.00235.x","article-title":"Role of cell adhesion molecules in leukocyte recruitment in the liver and gut. See comment in PubMed Commons below","volume":"84","author":"Ala","year":"2003","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.msard.2015.08.008_bib9","unstructured":"FDA Adverse Event Reporting System (FAERS). Freedom of Information Act. Detailed report 2009 to February 2014. 7."},{"key":"10.1016\/j.msard.2015.08.008_bib10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A Randomized placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2015.08.008_bib11","first-page":"189","article-title":"Natizumab for the treatment of relapsing multiple sclerosis. Biologics\u202f","volume":"2","author":"Rudick","year":"2008","journal-title":"Targets Ther."},{"key":"10.1016\/j.msard.2015.08.008_bib12","unstructured":"Available at: \u3008http:\/\/www.tysabrihcp.com\/pdfs\/I61061-PI.pdf12\u3009."},{"issue":"6","key":"10.1016\/j.msard.2015.08.008_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1191\/1352458505ms1239oa","article-title":"Autoimmune hepatitis and multiple sclerosis: a coincidental association?","volume":"11","author":"De Seze","year":"2005","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034815300018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034815300018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:38:08Z","timestamp":1761899888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034815300018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2211034815300018"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2015.08.008","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natalizumab-induced hepatic injury: A case report and review of literature","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}